ABSTRACT
INTRODUCTION
Ageing is characterized by a decline in functionality due to progressive loss of muscle tissue associated with a decrease in strength and force output. Low skeletal muscle strength has been shown to be an important predictor of all-cause mortality in healthy as well as diseased individuals (19, 20) . The increasing age of coronary artery disease (CAD) patients accompanied by 'fear of moving' and hospitalization in these patients often results in a substantial loss of skeletal muscle mass and muscle strength. It has also been shown that CAD patients suffer from increased muscle fatigability (13) . Regular physical activity in cardiac rehabilitation improves aerobic power and skeletal muscle strength and is associated with an increase in survival in these patients (15, 18, 37) . However individual differences in the response to rehabilitation are large (38), which may be partly related to genetic characteristics (28).
Heritability studies in humans have found a genetic contribution up to 66% to fat free mass (FFM) (1) and up to 65% to muscle strength (21). Studies in older twins reported that heritability could explain 20% to 52% of the variance in handgrip strength, leg extensor power and maximal walking speed (2, 7, 12, 21, (32) (33) (34) (35) . Heritability for handgrip strength seems to decrease with increasing age, with a concurrent increase of the relative contribution of environmental effects (7) . However, when excluding individuals with age-related chronic diseases, heritability estimates were found to increase (12) . Muscle cross sectional area (CSA) of upper and lower extremities among young individuals, showed to have a heritability up to 85-95% (17,29,30). In female twins, genetic effects accounted for 52-84% of the explained variance in lean body mass (26). High heritability estimates have been found in different muscular phenotypes, with multivariate genetic studies showing a shared genetic effect for different muscular characteristics (9, 29, (31) (32) (33) . Linkage studies performed on different muscular characteristics have found evidence for shared chromosomal regions (10) .
Over the last decade the number of studies trying to identify genetic sequence variation related to muscular phenotypes has increased enormously. In some candidate genes like ACE, ACTN3, CNTF and MSTN, specific variants have been repeatedly studied to test for associations in different population groups with different strength measures, albeit with varying success. In more recent years with the introduction of genome wide association studies (GWAS) (16) and genome wide linkage studies (GWLS) (11, 31, 34) , novel genes for muscular strength-related phenotypes have emerged. However to date, most studies have focussed on associations between single SNPs in single genes and strength phenotypes, with only few studies evaluating haplotype-phenotype associations (reviewed in 6). Most significant associations represented only a small proportion of explained variance in the studied strength phenotypes.
To the best of our knowledge, no study has been executed combining strength-increasing alleles of multiple 'strength' genes into a genetic predisposition score (GPS) to search for possible associations with different muscular phenotypes in a non-athlete population. This approach has been performed previously in endurance phenotypes (23-25, 39) and in the prediction of elite power-related performance (24).
Therefore the aim of this study was to identify the role of a GPS-score based on earlier identified gene variants for different muscular endophenotypes (muscular structure, metabolism, cytokines, growth or differentiation factors, neurotropic factors and hormones) to explain the individual differences in muscle characteristics and the response to physical training in coronary artery disease (CAD) patients. Backward-regression based selection of phenotype-specific SNPs to be included in each GPS-score was applied in this study, as was introduced by Bouchard et al. (5) . A secondary aim of this study was to compare this approach with the construction of a total GPS-score based on all 54 genotyped SNPs (GPS 54 ). We hypothesized a significant contribution for the GPS score to explain -at least in part-the variability in strength gain in CAD patients following rehabilitation.
METHODS

Study Sample and training intervention
All patients with CAD (acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting and/or angina pectoris), who were submitted to the cardiac rehabilitation program at the University Hospital in Leuven, were invited to participate in the CAREGENE II study (CArdiac REhabilitation and GENetics of Exercise performance). Patients with valve disease, congenital heart disease, major arrhythmia, pacemaker or ICD implantation, heart transplantation or other cardiac diseases were excluded. Inclusions were held from October 2008 until January 2011. The study protocol was approved by the Ethical Committee of the Faculty of Medicine of the Catholic University of Leuven and written informed consent was obtained from each participant. In total, 260 CAD patients, who had performed a graded cycle ergometer test with respiratory gas analysis until exhaustion, were included at baseline. Data at peak exercise was collected before and after 3 months of rehabilitation. Patients followed a standard ambulatory supervised cardiac rehabilitation program, three times per week for three months with 90 minutes/session involving cycling, running, arm ergometry, rowing, predominantly isotonic calisthenics and relaxation. The average training frequency was 2.26 ± 0.03 times/week and each patient trained on average at an intensity of 80 ± 0.82% (training heart rate/peak heart rate) x100, where the mean exercise heart rates of the last three exercise sessions A C C E P T E D and peak heart rates of the exercise testing after training were used. Two hundred and four patients completed the 3-month cardiac rehabilitation program and were included for the analyses of responses to training. The following tests were held before and after three months of rehabilitation.
Estimates for body composition
Six skinfolds located at the biceps, triceps, sub scapula, suprailiaca, mid-thigh, and medial-calf area were taken with a Harpenden-calliper. Stature and weight were measured and percentage of body fat and fat free mass (FFM) were estimated using an OMRON hand-held body fat monitor (Omron BF 300; OMRON, Matoukasa Co. Ltd, Japan).
Muscular strength
Isokinetic testing equipment (BIODEX System 3 Pro, Biodex Medical Systems, 20
Ramsay Road, Shirley, New York, USA) was used to determine the maximal knee flexion-and extension torque and muscular endurance. Isometric knee extension strength (KES) was measured at a 60° knee angle, isokinetic KES was measured at two contraction speeds (60°/s and 180°/s) and quadriceps muscle endurance was assessed by the total work delivered during a 25 repetition knee extension-flexion bout at a contraction speed of 180°/s. Patients were seated in an upright position with hips and knees 90° flexed. Straps were firmly fastened around the chest, hips and upper leg to stabilize the trunk and leg. Verbal encouragement was given to achieve maximal effort. Due to a technical problem with the BIODEX testing device, muscle strength of 14 patients at baseline and 15 patients post rehabilitation could not be tested. This led to a loss of 29 tests for the response in muscular strength to training.
Measurements of Rectus femoris diameter
Rectus femoris (RF) diameter was measured by M-mode ultrasonography, wall tracking ultrasound system (Siemens Vivid 07 GE) with a 12 MHz linear array transducer (12 L transducer GE). The transducer was placed perpendicular to the long axis of the thigh with excessive use of contact gel and minimal pressure to avoid compression of the muscle (3, 8) . The diameter of the RF was measured at the half point of the length between epicondylus lateralis and trochanter major of the femur. Measurements were taken on the patient's right leg with the patient lying in a supine position with both knees extended but relaxed and toes pointing the ceiling. A set of five pictures was taken and further analyzed offline. Both pre-and postrehabilitation ultrasound measurements were analyzed blind and at random. At baseline 246 patients were measured and 173 after training. The main causes for missing values were technical in nature; a server crash of the ultrasound system or the inability to visualize the inner wall of the RF with ultrasound. All ultrasound measurements were performed by a single experienced investigator (T.T) and this method was validated against CT in a similar population (27).
Genotyping
Anonymously coded blood samples were drawn from each patient. Genotyping was performed in a blinded manner using iPLEX technology on a MassARRAY Compact Analyser (Sequenom Inc., San Diego, CA, USA). Selection of SNPs was based on recent review articles, GWAS and GWLS up to January 2011 in which potential candidate genes, SNPs and regions were identified for either aerobic capacity, muscular strength or muscular endurance as A C C E P T E D phenotypes (5, 6, 10, 11, 25, 31, 36 
Statistical analyses
Data were analyzed using SAS statistical software version 9.2 for Windows (SAS Institute Inc, Cary, NC, USA). Data were reported as means ± standard deviation (SD) for anthropometric measurements, RF diameter and muscle strength measurements or as number of patients with percentage for dichotomous variables. To test whether the observed genotype frequencies were in Hardy-Weinberg equilibrium a ²-test with one degree of freedom was used.
Since multiple testing induces false positive or negative associations, and correction of p-values accordingly will lower the power to identify small genetic effects, 'increasing allele' genetic predispositions score (GPS) analysis was performed in which the number of increasing alleles was regressed against the phenotypes of interest. Based on our data, backward regression analysis was first applied to detect subsets of SNPs to be associated with the different muscular phenotypes and for which the GPS scores were calculated. Only these significant contributing SNPs were included in the GPS score. The number of significant contributing SNPs and its following GPS score were therefore different between the different phenotypes. An additive effect was hypothesized and equal weights were given for each increasing allele, because no well-defined effect sizes were known for the different SNPs and weighting of increasing alleles might only have limited effects (14) . GPS was calculated for each individual by adding the As an alternative approach we created a total GPS score (GPS 54 ) based on the total set of 54 SNPs for isokinetic KES at 180°/s, in order to compare the amount of explained variance of an overall approach (GPS 54 ) with the GPS based on a significant subgroup of SNPs after backward regression. Isokinetic KES at 180°/s was used as this is a measurement which has a wide spread use within muscle testing and since the training regimen in cardiac rehabilitation was predominantly dynamic in nature. ANCOVA analysis and multiple regression were used to test the association and percentage explained variance of GPS 54 in baseline and response to training values. The power of the total GPS 54 to discriminate between high and low responders was analysed using ROC and AUC and adjusted odds were calculated. All statistical tests were performed two-sided at a significance level of 5%.
RESULTS
Descriptive baseline patient characteristics, cardiac history, medication use and response to three months of cardiac rehabilitation are described in table 1. Baseline characteristics did not differ between the patients who dropped-out of the study and the patients who participated for three months. PeakVO 2 increased by 21.6 ± 15.9% (p<0.001) and peak heart rate by 8.2% ± 11.9% after 3 months of training, isometric KES increased by 11.5 ± 16.0% (p<0.0001), isokinetic KES (60°/s) by 17.0 ± 23.1% (p<0.0001), isokinetic KES (180°/s) by 16.5 ± 20.2% (p<0.0001) and isokinetic quadriceps muscle endurance by 18.8 ± 23.3% (p<0.0001) ( Table 2) . RF diameter was increased by 5.4 ± 11.2% (p<0.0001). Body weight remained similar whilst relative and absolute values of body fat decreased significantly by approximately 3% (p<0.001) ( Table 2) .
A C C E P T E D
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Backward regression analysis revealed subsets of SNPs to be significantly associated with the respective muscular phenotypes at baseline and the response to training (strength and RF diameter). In particular, we identified 2 SNPs for baseline isometric and isokinetic KES (60°/s) and up to 11 SNPs for the response of RF diameter and knee extensor endurance strength. Table 2 (Supplemental Digital Content 2, http://links.lww.com/MSS/A223) gives an overview of the SNPs included in the GPS score for each baseline and response phenotype. Only these significantly contributing SNPs were included in the GPS score. To avoid the possibility of false positive or negative results and the lack of statistical power by the smaller groups at the two tails -small number of patients with either a small or high number of increasing alleles-we combined the two lower and two upper GPS score groups respectively. Results of ANCOVA analyses of the GPS influence on baseline and response variables, with age, sex, height and FFM as covariates for baseline measurements and age, sex, height, change in FFM, TI and TF for response measurements, are shown in Figure 1 . Proc GLM showed that each GPS-score was significantly associated with RF diameter (p<0.01) and RF diameter response (p<0.0001), isometric KES (p<0.05) and change in isometric KES (p<0.01), isokinetic KES at 60°/s (p<0.05) and 180°/s (p<0.001) and their respective response to training (p<0.0001) and isokinetic knee extensor muscle endurance (p<0.001) and its change after three months of training (p<0.0001).
Stepwise multiple regression analysis showed a total explained variance between 36% and 57% for the baseline muscle phenotypes (Table 3) . GPS score was found as an independent determinant in all baseline muscle phenotypes except for baseline isometric knee extension strength with partial r between 0.16 and 0.30 (Table 3 ). The significant b-coefficients in table 3 indicate that each increasing allele in the GPS score results in an additional 6.65 Nm, 3.47 Nm, 124.62 J and 0.04 cm in baseline isokinetic KES (at 60°/s and 180°/s), baseline muscle A C C E P T E D endurance and baseline RF diameter respectively. GPS 54 was not significantly related to baseline isokinetic KES at 180°/s. Table 4 shows the multiple stepwise regression analysis for the training response parameters. Total explained variance ranged between 6% and 26% with GPS as a significant independent determinant in all response phenotypes (r between 0.25 and 0.48). Each additional increasing allele adds 6.92% to the gain in isometric KES, 1.38% in isokinetic KES at 60°/s, 6.60% in isokinetic KES at 180°/s, 7.60% in knee extension endurance and adds 3.38% to the gain in RF diameter. Analyses of the high vs. low-responder groups were performed for the GPS of all phenotypes after training. For all response phenotypes GPS was the only statistically significant contributing variable, except for the response in isokinetic KES at 180°/s for which change in fat free mass was an additional significant predictor. Results per phenotype are shown in table 5.
Additionally we performed an analysis on the GPS 54 score, based on the 54 selected SNPs, for isokinetic KES at 180°/s and the response after training. Although there was a theoretical spread of GPS 54 score between 0 and 108, the GPS 54 ranged from 42 to 60 for baseline and between 40 and 65 for the sample with response data. The groups at the two tails were combined and the GPS 54 was analyzed with a spread from 46 to 57 for baseline and 47 to 58 for the response. When GPS 54 was analyzed without covariates for isokinetic KES (180°/s) at baseline a trend could be observed that a higher GPS 54 results in a higher baseline KES (P=0.06).
When age, sex, height and FFM were added as covariates the model was significant (P<0.001), however, GPS 54 had no significant contribution (P=0.50). For the response in isokinetic KES (180°/s), GPS 54 was a significant (P<0.001) independent variable when analyzed without covariates and the model with covariates was also significant (P<0.01). In the latter procedure, GPS was the only significant contributor to the model (partial P=0.0029). When GPS 54 was 
DISCUSSION
Since most previous genetic association analysis studies mainly focus on one phenotype and one gene (variant), the first aim of this study was to identify combinations of gene variants that were associated with different muscular phenotypes and to quantify the degree of explained variances of these GPS-scores for the variability in strength and strength gains in CAD patients.
In this study we found an increase in muscle strength between 11% and 17% and in RF diameter of 5% after three months of rehabilitation in CAD patients with a predominantly aerobic exercise-training program. However a large inter-individual variability could be observed. information. However, muscular strength phenotypes are multifactorial and polygenic traits. To the best of our knowledge, this was the first study to search for combinations of SNPs in different muscular (endophenotype) related genes. By means of backward regression analysis, we were able to identify 10 sets of SNPs to be associated with different muscular phenotypes. rs17602729 in the AMPD1 gene and rs1016732 and rs2854248 in the ATP1A2 gene showed a large overlap between the different strength phenotypes. Rs17602729 of the AMPD1 gene has previously been shown to be associated with a diminished aerobic capacity and cardiorespiratory response to exercise (22,28) and a decrease in exercise duration over 20 years (25). Likewise markers from ATP1A2 were associated with a decrease in exercise duration (25). The majority of SNPs included in the GPS-scores for these muscular phenotypes were located in genes that were functionally categorized into muscle metabolism or muscle growth and differentiation.
ANCOVA analyses showed that all created GPS-scores were significantly associated with their respective phenotype under study. At baseline, CAD patients with a higher GPS-score showed higher baseline isometric and isokinetic knee extensor strength, with every additional increasing allele accounting for a surplus in strength. Subjects with a higher GPS also showed a higher muscle strength or muscular endurance response to training. Moreover, we were able to show that GPS contributes significant to the discrimination between high and low responders status for the phenotypes under study. GPS had a significant AUC between 0.62 and 0.85 and adjusted odds ratio between 1.90 and 2.84 for the different muscular phenotypes. A patient with a high GPS has a higher probability to end up in the group with the 25% highest response after training. For all phenotypes under study, GPS was the best independent variable associated with a high-responder status and except for isokinetic KES at 180°/s, it was the only contributor to high-response values.
A C C E P T E D
The GPS-score was an independent determinant for all, except isometric extensor strength, baseline phenotypes with a partial R² ranging between 3% and 9% (Table 3) . For the response to training only the change in FFM and age were previously found as determining variables for some response phenotypes ( Table 4 ). The partial explained variance by adding the GPS-score for the response to training had a R² between 6% and 23%. The higher explained variance by the GPS of the difference in response to training, compared to the baseline measurement, might be explained by the higher number of other determinants at baseline. At baseline the largest part of the variability in muscle strength and diameter could be explained by covariates such as age, sex, height and FFM, which are already under genetic influence.
Furthermore, effect sizes of gene variants might be larger when the muscular system is challenged to be active in repair and metabolic optimization in response to regular training, compared to a stable baseline condition.
Related to the secondary aim of this study we compared two strategies to determine the genetic predisposition score. The option to determine each GPS-score phenotype-specific based on significantly contributing SNPs is less practical in further applications of this approach as the set of SNPs differs according to different phenotypes. This approach might also inflate the probability of finding significant GPS-phenotype associations. An overall GPS-score based on all 54 SNPs (GPS 54 ) was calculated and compared with the GPS-score based on the significant subsets of SNPs for isokinetic KES at 180°/s at baseline and the response after training. Indeed, the explained variance in response to training was higher when the GPS score was based on the significant subgroup of SNPs (13.7%) when compared to GPS 54 (9.5%). Both approaches proved . By first using a backward regression analysis on the total group of SNPs we, and others who applied this similar approach (5), were able to filter out the SNPs that had very small contributions or no influence on the phenotype under study. Inherent to the chosen construction of the GPS-scores (whether as a total set of SNPs or subset of SNPs), we assumed allelic effects to be co-dominant and each SNP to have an equal additional effect. Also by using GPS-scores, information on which combination of increasing alleles is responsible for the specific effect is lost, as individuals with 4 increasing alleles, might possess those from various combinations of increasing alleles of different gene variants. Finally, we are aware that the selection of genes in the initial gene list might have left out other SNPs that might be associated with muscular phenotypes.
There are some limitations to this study. This study was performed in a predominantly Caucasian, older, male CAD population. According to required sample sizes in genetic epidemiological studies, the sample size is small (4). This approach therefore needs further replication and results might be expected to be different in other populations or in response to other exercise regimens. The cardiac rehabilitation training was mostly focused on aerobic training with a smaller part of dynamic resistance training (3 sets of 15 reps) of the lower extremities with own body weight as resistance. Unfortunately some measuring devices had technical errors so in some individuals not all tested parameters were available. Additionally there is a reasonable dropout rate in patients following cardiac rehabilitation due to work resume or long distance to the rehabilitation center, which led to a lower number of response measurements. However sub-analyses of dropout versus non-dropout groups did not reveal significant differences between both groups at the start of the rehabilitation.
CONCLUSIONS
Constructions of multiple SNPs into genetic predisposition scores (GPS) for different muscular phenotypes showed to be associated with baseline muscle strength, muscle diameter and the response of these parameters to training in cardiac rehabilitation patients. The GPS-score could explain up to 23% of the variance in these muscular phenotypes and was able to discriminate high versus low responder status on different muscular phenotypes. Phenotypespecific GPS-scores selected by backward regression show higher GPS-phenotype associations compared to the application of a GPS-score based on all listed gene variants. 
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